Sherman Michael A. — SEC Form 4 filings

SEC reporting owner CIK 1509463. 4 Form 4 filings on record with FilingPulse; latest filed 2025-06-13.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-05-24 to 2025-06-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CHIMERIX INC (CMRX)Chief Executive Officer, Director210
Werewolf Therapeutics, Inc. (HOWL)Director22

Form 4 filings — Sherman Michael A.

FiledFormIssuerReported transactionsSource
2025-06-134Werewolf Therapeutics, Inc. (HOWL)Grant/award (A): 27,000 (derivative) @ $0EDGAR
2025-04-214CHIMERIX INC (CMRX)Disposition to issuer (D): 87,000 @ $8.55 · Disposition to issuer (D): 102,995 @ $8.55 · Disposition to issuer (D): 233,413 @ $8.55 · Disposition to issuer (D): 1,150,000 (derivative) · Disposition to issuer (D): 632,500 (derivative) · Disposition to issuer (D): 700,000 (derivative) · +3 moreEDGAR
2024-06-214CHIMERIX INC (CMRX)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2024-05-244Werewolf Therapeutics, Inc. (HOWL)Grant/award (A): 17,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1509463 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →